An investigator-sponsored, open-label, single dose, safety and tolerability study clinical study of a Durasert implant to treat severe OA of the knee.
Phase of Trial: Phase I
Latest Information Update: 04 May 2017
At a glance
- Drugs Dexamethasone (Primary)
- Indications Osteoarthritis
- Focus Adverse reactions
- 04 May 2017 According to pSivida media release, the company expects to to report the initial 24-week data by the fourth quarter of 2017.
- 07 Feb 2017 According to pSivida media release, to date five patients have received the implant and HSS expects to have the final patient implanted within the next month.
- 14 Nov 2016 New trial record